Edition:
United States

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

59.19USD
20 Apr 2018
Change (% chg)

$-0.69 (-1.15%)
Prev Close
$59.88
Open
$59.95
Day's High
$59.95
Day's Low
$58.82
Volume
1,995,088
Avg. Vol
1,915,370
52-wk High
$64.60
52-wk Low
$42.88

Select another date:

Wed, Apr 18 2018

Photo

Abbott sticks to earlier forecasts, disappoints investors

Abbott Laboratories' just beat expectations for first quarter profits and revenue on Wednesday but stuck to a full-year profit forecast some investors had expected would be raised, sending the healthcare company's shares lower.

UPDATE 3-Abbott sticks to earlier forecasts, disappoints investors

* Analysts cite disappointment on whisper numbers among investors

BRIEF-Abbott Q1 GAAP Earnings Per Share $0.23 From Continuing Operations

* Q1 GAAP EARNINGS PER SHARE $0.23 FROM CONTINUING OPERATIONS

Abbott Labs' quarterly revenue rises 16.7 percent

April 18 Abbott Laboratories on Wednesday posted a 16.7 percent rise in quarterly revenue, helped by strong demand for its newer devices.

BRIEF-Abbott Initiates Trial To Evaluate Improved Survival And Outcomes With The Cardiomems Monitor

* ABBOTT INITIATES TRIAL TO EVALUATE IMPROVED SURVIVAL AND OUTCOMES WITH THE CARDIOMEMS MONITOR

Abbott's Alere resolves U.S. diagnostic device probe for $33.2 mln

BOSTON, March 23 Alere Inc has agreed to pay $33.2 million to resolve claims it knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories last year, the U.S. Justice Department said on Friday.

BRIEF-Abbott's MitraClip Therapy Receives National Reimbursement In Japan To Treat Patients With Mitral Regurgitation

* ABBOTT'S MITRACLIP THERAPY RECEIVES NATIONAL REIMBURSEMENT IN JAPAN TO TREAT PATIENTS WITH MITRAL REGURGITATION

BRIEF-Abbott Laboratories CEO Miles White's Total Compensation,Without Change In Pension Value Was $16.8 Mln V/s $17.4 Million In 2016

* ABBOTT LABORATORIES CEO MILES D. WHITE'S 2017 TOTAL COMPENSATION(TOTAL WITHOUT CHANGE IN PENSION VALUE) WAS $16.8 MILLION VERSUS $17.4 MILLION IN 2016 – SEC FILING‍​ Source text (http://bit.ly/2IwpJvl) Further company coverage: (Reuters.Brief@thomsonreuters.com)

Judge slams wholesaler for discovery abuse in Abbott trademark fight

A federal judge on Friday allowed Abbott Laboratories to question a wholesaler and its former lawyer about why they withheld documents sought by the healthcare giant in a trademark infringement case, saying there is probable cause to believe they engaged in discovery fraud.

Select another date: